Research Directory

Interview: 4-Antibody AG - How do you structure a biotech for divestment?

Read more

A Big Pharma deal that shares risk and reward

Read more

Focus on ophthalmology: new treatment modality

Read more

European biotechs rebound sharply

Read more

Due diligence is more than a numbers game

Read more

Kymab unlocks the power of the mouse

Read more

Reforming the EU Clinical Trials Directive

Read more

The outlook for new clinical trials legislation in Europe

Read more

HTA and the road to higher pharma productivity

Read more

The role of technology providers in biotech

Read more